Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4068 | 1777 | 31.7 | 61% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
762 | 11723 | NEUROENDOCRINE TUMORS//CARCINOID//GASTRINOMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INSULINOMA | Author keyword | 113 | 38% | 14% | 240 |
2 | GASTRINOMA | Author keyword | 79 | 47% | 7% | 125 |
3 | ZOLLINGER ELLISON SYNDROME | Author keyword | 61 | 48% | 5% | 93 |
4 | ORGANIC HYPERINSULINISM | Author keyword | 11 | 78% | 0% | 7 |
5 | GASTRIC ACID HYPERSECRETION | Author keyword | 9 | 83% | 0% | 5 |
6 | INSULINOMAS | Author keyword | 7 | 43% | 1% | 13 |
7 | ZOLLINGER ELLISON | Author keyword | 7 | 67% | 0% | 6 |
8 | MALIGNANT INSULINOMA | Author keyword | 6 | 50% | 1% | 9 |
9 | PROLONGED FAST | Author keyword | 6 | 100% | 0% | 4 |
10 | SELECTIVE ARTERIAL CALCIUM INJECTION TEST | Author keyword | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INSULINOMA | 113 | 38% | 14% | 240 | Search INSULINOMA | Search INSULINOMA |
2 | GASTRINOMA | 79 | 47% | 7% | 125 | Search GASTRINOMA | Search GASTRINOMA |
3 | ZOLLINGER ELLISON SYNDROME | 61 | 48% | 5% | 93 | Search ZOLLINGER+ELLISON+SYNDROME | Search ZOLLINGER+ELLISON+SYNDROME |
4 | ORGANIC HYPERINSULINISM | 11 | 78% | 0% | 7 | Search ORGANIC+HYPERINSULINISM | Search ORGANIC+HYPERINSULINISM |
5 | GASTRIC ACID HYPERSECRETION | 9 | 83% | 0% | 5 | Search GASTRIC+ACID+HYPERSECRETION | Search GASTRIC+ACID+HYPERSECRETION |
6 | INSULINOMAS | 7 | 43% | 1% | 13 | Search INSULINOMAS | Search INSULINOMAS |
7 | ZOLLINGER ELLISON | 7 | 67% | 0% | 6 | Search ZOLLINGER+ELLISON | Search ZOLLINGER+ELLISON |
8 | MALIGNANT INSULINOMA | 6 | 50% | 1% | 9 | Search MALIGNANT+INSULINOMA | Search MALIGNANT+INSULINOMA |
9 | PROLONGED FAST | 6 | 100% | 0% | 4 | Search PROLONGED+FAST | Search PROLONGED+FAST |
10 | SELECTIVE ARTERIAL CALCIUM INJECTION TEST | 6 | 100% | 0% | 4 | Search SELECTIVE+ARTERIAL+CALCIUM+INJECTION+TEST | Search SELECTIVE+ARTERIAL+CALCIUM+INJECTION+TEST |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ISLET CELL TUMORS | 176 | 44% | 17% | 307 |
2 | ZOLLINGER ELLISON SYNDROME | 102 | 29% | 17% | 299 |
3 | DUODENAL GASTRINOMAS | 96 | 86% | 3% | 49 |
4 | GASTRINOMAS | 77 | 53% | 6% | 103 |
5 | HYPOGLYCEMIC DISORDERS | 59 | 90% | 1% | 26 |
6 | INTRAARTERIAL CALCIUM STIMULATION | 42 | 83% | 1% | 24 |
7 | SECRETIN INJECTION TEST | 34 | 93% | 1% | 13 |
8 | INSULINOMAS | 33 | 36% | 4% | 75 |
9 | LOCALIZING INSULINOMAS | 32 | 88% | 1% | 15 |
10 | PANCREATIC INSULINOMAS | 31 | 74% | 1% | 23 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Diagnosis and management of insulinoma | 2013 | 18 | 76 | 63% |
Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies | 2008 | 97 | 316 | 41% |
Pancreatic insulinoma: current issues and trends | 2010 | 20 | 65 | 58% |
Insulinoma: pathophysiology, localization and management | 2010 | 14 | 71 | 63% |
Management of sporadic and multiple endocrine neoplasia type 1 gastrinomas | 2007 | 26 | 92 | 74% |
Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome | 2004 | 94 | 225 | 59% |
Gastric secretion in Zollinger-Ellison syndrome - Correlation with clinical expression, tumor extent and role in diagnosis - A prospective NIH study of 235 patients and a review of 984 cases in the literature | 2001 | 53 | 135 | 79% |
MRI of pancreatic neuroendocrine tumours | 2001 | 71 | 8 | 63% |
Zollinger-Ellison syndrome - Clinical presentation in 261 patients | 2000 | 114 | 136 | 68% |
Effective Therapy of Insulinoma by Using Long-Acting Somatostatin Analogue. A Case Report and Literature Review | 2012 | 7 | 16 | 63% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SURG METAB SECT | 4 | 25% | 0.8% | 14 |
2 | DIGEST DIS BRANCH | 4 | 11% | 1.7% | 30 |
3 | DDB | 3 | 29% | 0.5% | 8 |
4 | ENDOCRINOL DIABETOL NEPHROL ANGIOL CLIN CHE | 2 | 67% | 0.1% | 2 |
5 | GENEM | 2 | 67% | 0.1% | 2 |
6 | CLIN CELLULAR BIOL SECT | 1 | 100% | 0.1% | 2 |
7 | HOSP UNIV RANGUEIL LARREY | 1 | 100% | 0.1% | 2 |
8 | CLIN CHIRURG ADULTE EST | 1 | 40% | 0.1% | 2 |
9 | KLIN VISCERAL THORAX GEFAS IRURG | 1 | 13% | 0.3% | 6 |
10 | AREA SURG | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000194323 | NECROLYTIC MIGRATORY ERYTHEMA//SUPERFICIAL NECROLYTIC DERMATITIS//HEPATOCUTANEOUS SYNDROME |
2 | 0.0000181470 | ONCOCYTIC MENINGIOMA//ISLET CELL NEOPLASM//ONCOCYTIC TRANSFORMATION |
3 | 0.0000177231 | NEUROENDOCRINE TUMORS//CARCINOID//CARCINOID HEART DISEASE |
4 | 0.0000149563 | NON ISLET CELL TUMOR HYPOGLYCEMIA NICTH//BIG IGF II//NICTH |
5 | 0.0000123443 | GANGLIOCYTIC PARAGANGLIOMA//SOMATOSTATINOMA//GANGLIONEUROMATOSIS |
6 | 0.0000122590 | CONGENITAL HYPERINSULINISM//NESIDIOBLASTOSIS//HYPERINSULINISM |
7 | 0.0000119144 | PARATHYROID CARCINOMA//MENIN//MEN1 |
8 | 0.0000106248 | INSULIN OVERDOSE//REACTIVE HYPOGLYCEMIA//BIOCHEMICAL HYPOGLYCEMIA |
9 | 0.0000098447 | REFRACTORY DIARRHEA//MCKITTRICK WHEELOCK SYNDROME//DUMPING SYNDROME |
10 | 0.0000097329 | SOMATOSTATIN RECEPTOR SCINTIGRAPHY//PEPTIDE RECEPTOR RADIONUCLIDE THERAPY//OCTREOTATE |